Brain aneurysm device under Real-World watch: will it hold up?
NCT ID NCT05071963
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 246 people who received the Pipeline Shield device to treat brain aneurysms. The device is a small mesh tube that blocks blood flow to the aneurysm, reducing rupture risk. Researchers are checking how well the aneurysm seals, whether the artery narrows, and if repeat treatment is needed within one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pipeline™ Flex Embolization Device with Shield Technology™ (a device used to block blood flow to brain aneurysms)
What this could lead to
If successful, this study could confirm that the Pipeline Shield device is a safe and effective option for treating brain aneurysms in everyday medical practice.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove the device is better than other treatments. Risks include incomplete aneurysm sealing or artery narrowing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baptist Medical Center Jacksonville
Jacksonville, Florida, 32207, United States
-
Baylor Scott & White Research Institute
Dallas, Texas, 75201, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Endeavor Health - Evanston Hospital
Evanston, Illinois, 60201, United States
-
Geisinger Medical Center
Danville, Pennsylvania, 17822-9800, United States
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Montefiore Medical Center
New York, New York, 10467-2401, United States
-
NYU Langone Medical Center
New York, New York, 10016-6402, United States
-
Norton Healthcare
Louisville, Kentucky, 40202, United States
-
Oklahoma (OU) University Medical Center
Oklahoma City, Oklahoma, 73104, United States
-
Prisma Health
Greenville, South Carolina, 29605, United States
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Utah Hospital
Salt Lake City, Utah, 84132-0001, United States
-
Washington University in Saint Louis
St Louis, Missouri, 63130, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States